Peering Into West Pharmaceutical Servs’s Recent Short Interest
West Pharmaceutical Servs’s (NYSE:WST) short percent of float has risen 9.04% since its last report. The company recently…
How Is The Market Feeling About West Pharmaceutical Servs?
West Pharmaceutical Servs’s (NYSE:WST) short percent of float has fallen 13.37% since its last report. The company recently…
(WST) – Analyzing West Pharmaceutical Servs’s Short Interest
West Pharmaceutical Servs’s (NYSE:WST) short percent of float has risen 8.42% since its last report. The company recently…
S&P Reclaims 5,000 As Disappointing Retail Sales Put Fed Cuts Back On Track, Small Caps Shine: What’s Driving Markets Thursday?
US stocks surge on strong earnings and speculation of Fed rate cuts. S&P 500 rebounds past 5000, Nasdaq 100 pauses. Small caps outperform. Tesla, Wells Fargo, and CBRE rally on positive news while Deer & Antero Resources shares drop. Other companies react to earnings.
Why Herbalife Shares Are Trading Lower By Around 36%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session
Shares of Herbalife Ltd. (NYSE: HLF) fell sharply in today’s session following weak quarterly earnings.
West Pharmaceutical’s 2024 Outlook Cautious, Analysts Remain Optimistic
West Pharmaceutical Services reports Q4 2023 adjusted EPS at $1.83, surpassing consensus. Quarterly sales hit $732 million missing estimates. 2024 guidance hints at moderated organic growth, emphasizing inventory management strategies.
(WST) – Analyzing West Pharmaceutical Servs’s Short Interest
West Pharmaceutical Servs’s (NYSE:WST) short percent of float has risen 8.42% since its last report. The company recently…
Earnings Scheduled For February 15, 2024
Companies Reporting Before The Bell
• Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million.
Keybanc Maintains Overweight Rating for West Pharmaceutical Servs: Here’s What You Need To Know
Keybanc has decided to maintain its Overweight rating of West Pharmaceutical Servs (NYSE:WST) and raise its price target…
TransDigm, West Pharmaceutical, Thermo Fisher Scientific And A Tech Company On CNBC’s ‘Final Trades’
On CNBC’s "Halftime Report Final Trades," Steve Weiss of Short Hills Capital Partners named TransDigm Group Incorporated (NYSE: TDG), which is scheduled to release